Menu

Press Releases

Proin® Receives FDA Approval

Pegasus Laboratories, Inc. (Pegasus), announces that Proin® (phenylpropanolamine hydrochloride) Chewable Tablets has received a New Animal Drug Approval (NADA #141-324) from the U.S. Food & Drug Administration Center of Veterinary Medicine. Proin is approved for the control of canine urinary incontinence due to urethral sphincter hypotonus.

“The R&D performed to receive this NADA not only demonstrates the safety and effectiveness of Proin, but further demonstrates the commitment of Pegasus to provide trusted products to Veterinarians and their clients.  Proin has been the product of choice by Veterinarians for the control of canine urinary incontinence to ensure the bond between the pet owner and the pet is not impacted due to urinary incontinence”, said Pegasus President Don Chew.

Proin is manufactured by Pegasus Laboratories, Inc. under the PRN Pharmacal brand and is available nation-wide through veterinary distributors. Pegasus has over 30 years of service to the veterinary pharmaceutical industry with a production facility in Pensacola, Florida. For more information on Proin, visit prnpharmacal.com/proin or call 1-800-874-9764.